Antimicrobial peptide that displays antibacterial and antiprotozoal activity (PubMed:32967114). Exhibits antibacterial activity against the Gram-positive bacteria S.epidermidis ATCC 12228 (MIC=2 uM), E.casseliflavus ATCC 700327 (MIC=16 uM), S.aureus ATCC 25923 (MIC=4 uM) and E.faecalis ATCC 29212 (MIC=8 uM), and the Gram-negative bacteria E.coli ATCC 25922 (MIC=16 uM) and K.pneumoniae ATCC 13883 (MIC=4 uM) (PubMed:32967114). Displays antiprotozoal activity against the epimastigote form of T.cruzi (IC(50)=15.9 uM) (PubMed:32967114). Does not show antimicrobial activity against the Gram-negative bacterium P.aeruginosa ATCC 27853, or the fungi C.albicans ATCC 90028 and C.parapsilosis ATCC 22019 (PubMed:32967114). Shows high cytolytic activity against human erythrocytes (HC(50)=10 uM), and displays anti-proliferative effects against various cancer cell lines including MCF-7 breast cancer cells (IC(50)=13.7 uM), HeLa cervical adenocarcinoma cells (IC(50)=11.1 uM) and B16F10 murine melanoma cells (IC(50)=10.5 uM) (PubMed:32967114). Expressed by the skin glands. Belongs to the frog skin active peptide (FSAP) family.